glp 1 diabetes The role of GLP1 receptor agonists in adult-onset type mellitus GLP-1a: Going beyond Traditional Use
Description
36-38 Adverse reactions and tolerability: The most common adverse reactions associated with SGLT- 2 inhibitor therapy include an increased risk of certain infections and volume status-related events

Clinical trials have shown that GLP-1R agonists increase microvascular blood volume and flow in cardiac muscle, and these effects are preserved in obese individuals with vascular insulin resistance

doi: 10.1056/NEJM199503093321001

Drug and Alcohol Dependence, 179, 229239

doi:10.1001/jamapsychiatry.2025.4308 Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, Tow AC, Dermody SS, Prince MA, Jordan R, McKee SA, Fletcher PJ, Claus ED, Klein KR
